These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16182986)

  • 41. Agitation during prolonged mechanical ventilation at a long-term acute care hospital: risk factors, treatments, and outcomes.
    O'Connor H; Al-Qadheeb NS; White AC; Thaker V; Devlin JW
    J Intensive Care Med; 2014; 29(4):218-24. PubMed ID: 23753245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [State of agitation. Diagnostic guidance and procedures in emergencies along with drug dosage recommendations].
    Haffen E; Sechter D
    Rev Prat; 1998 May; 48(10):1123-7. PubMed ID: 9781159
    [No Abstract]   [Full Text] [Related]  

  • 43. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effectiveness of electroconvulsive therapy in the light of current approaches to the treatment of febrile conditions in schizophrenia].
    Moshchevitin SIu; Tsygankov BD; Malin DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):114-21. PubMed ID: 1975144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Creatine phosphokinase in a hospitalized psychiatric population].
    Manero Marcén E; Malo Ocejo P; Uriarte Uriarte JJ; Pinilla Tubet E
    Arch Neurobiol (Madr); 1992; 55(5):235-40. PubMed ID: 1362345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involuntary medication treatment for competency restoration of 22 defendants with delusional disorder.
    Herbel BL; Stelmach H
    J Am Acad Psychiatry Law; 2007; 35(1):47-59. PubMed ID: 17389345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coerced treatment according to the right to treatment regulation: never contrary to the will of mentally competent patients].
    Weber M
    Pflege Z; 2007 Apr; 60(4):222-4. PubMed ID: 17494432
    [No Abstract]   [Full Text] [Related]  

  • 50. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia.
    Amodeo G; Fagiolini A; Sachs G; Erfurth A
    CNS Neurol Disord Drug Targets; 2017; 16(8):885-890. PubMed ID: 28933260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergency management of agitation in pregnancy.
    Ladavac AS; Dubin WR; Ning A; Stuckeman PA
    Gen Hosp Psychiatry; 2007; 29(1):39-41. PubMed ID: 17189743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of agitation in the acute psychotic patient--efficacy without excessive sedation.
    Cañas F
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S108-14. PubMed ID: 17336765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Approach to the Agitated Emergency Department Patient.
    Gottlieb M; Long B; Koyfman A
    J Emerg Med; 2018 Apr; 54(4):447-457. PubMed ID: 29395692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of the agitated patient.
    Kunkel EJ; Aliu O
    Del Med J; 2000 Nov; 72(11):473-8. PubMed ID: 11125663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A naturalistic study of consecutive agitated emergency department patients treated with intramuscular olanzapine prior to consent.
    Damsa C; Adam E; Lazignac C; Mihai A; DE Gregorio F; Lejeune J; Maris S; Clivaz E; Allen MH
    Am J Psychiatry; 2008 Apr; 165(4):535-6. PubMed ID: 18381919
    [No Abstract]   [Full Text] [Related]  

  • 58. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.
    Hamann J; Mendel RT; Fink B; Pfeiffer H; Cohen R; Kissling W
    J Nerv Ment Dis; 2008 Apr; 196(4):329-32. PubMed ID: 18414128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excited delirium syndrome (ExDS): treatment options and considerations.
    Vilke GM; Bozeman WP; Dawes DM; Demers G; Wilson MP
    J Forensic Leg Med; 2012 Apr; 19(3):117-21. PubMed ID: 22390995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.